Development of Biarylalkyl Carboxylic Acid Amides with Improved Anti‐schistosomal Activity

The parasitic disease schistosomiasis is the cause of more than 200 000 human deaths per year. Although the disease is treatable, there is one major shortcoming: praziquantel has been the only drug used to combat these parasites since 1977. The risk of the emergence of resistant schistosomes is know...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ChemMedChem
Main Authors: Peter Ventura, Alejandra M., Haeberlein, Simone, Lange‐Grünweller, Kerstin, Grünweller, Arnold, Hartmann, Roland K., Grevelding, Christoph G., Schlitzer, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Full Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7687077/
https://ncbi.nlm.nih.gov/pubmed/31454168
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.201900423
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados